Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios (Innolink: 100.918 IP-LS)

• Forschungsstelle: INNOSUISSE
• Projektnummer: 100.918 IP-LS
• Projekttitel Englisch: Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios (Innolink: 100.918 IP-LS)

Schlüsselwörter (Englisch)

Life sciences, Human medicine

Abstract (Englisch)

Accurate diagnosis is critical in determining the right therapy for carcinoma patients, leading to improved survival rates and quality of life. Nuclidium AG is developing Kalios, a diagnostic agent that enables precise imaging of carcinomas, overcoming all limitations of current imaging modalities.